108 related articles for article (PubMed ID: 8227483)
1. In vivo determinations of carbamazepine and carbamazepine-10, 11-epoxide binding parameters to serum proteins in monotherapy patients.
Kodama Y; Kuranari M; Kodama H; Fujii I; Takeyama M
J Clin Pharmacol; 1993 Sep; 33(9):851-5. PubMed ID: 8227483
[TBL] [Abstract][Full Text] [Related]
2. In vivo binding characteristics of carbamazepine and carbamazepine-10,11-epoxide to serum proteins in paediatric patients with epilepsy.
Kodama Y; Tsutsumi K; Kuranari M; Kodama H; Fujii I; Takeyama M
Eur J Clin Pharmacol; 1993; 44(3):291-3. PubMed ID: 8491247
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgery.
Gidal BE; Spencer NW; Maly MM; Pitterle ME
Epilepsia; 1996 Apr; 37(4):381-5. PubMed ID: 8603645
[TBL] [Abstract][Full Text] [Related]
4. In vivo binding characteristics of carbamazepine and carbamazepine 10, 11-epoxide to serum proteins in monotherapy adult patients.
Kodama Y; Kuranari M; Tsutsumi K; Okamoto T; Kodama H; Yasunaga F; Fujii I; Takeyama M
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):618-21. PubMed ID: 7874378
[TBL] [Abstract][Full Text] [Related]
5. Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein.
MacKichan JJ; Zola EM
Br J Clin Pharmacol; 1984 Oct; 18(4):487-93. PubMed ID: 6487490
[TBL] [Abstract][Full Text] [Related]
6. Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Tsutsumi K; Fujii I; Takeyama M
J Clin Pharmacol; 1995 Oct; 35(10):995-1002. PubMed ID: 8568018
[TBL] [Abstract][Full Text] [Related]
7. Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy.
Contin M; Riva R; Albani F; Perucca E; Lamontanara G; Baruzzi A
Eur J Clin Pharmacol; 1985; 29(2):211-4. PubMed ID: 4076320
[TBL] [Abstract][Full Text] [Related]
8. Altered serum protein binding of carbamazepine in disease states associated with an increased alpha 1-acid glycoprotein concentration.
Baruzzi A; Contin M; Perucca E; Albani F; Riva R
Eur J Clin Pharmacol; 1986; 31(1):85-9. PubMed ID: 3780833
[TBL] [Abstract][Full Text] [Related]
9. Free concentration of carbamazepine and carbamazepine-10,11-epoxide in children and adults. Influence of age and phenobarbitone co-medication.
Riva R; Contin M; Albani F; Perucca E; Procaccianti G; Baruzzi A
Clin Pharmacokinet; 1985; 10(6):524-31. PubMed ID: 4064451
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine and carbamazepine-epoxide serum protein binding in newborn infants.
Groce JB; Casto DT; Gal P
Ther Drug Monit; 1985; 7(3):274-6. PubMed ID: 4049463
[TBL] [Abstract][Full Text] [Related]
11. Distribution of carbamazepine and its epoxide in blood compartments in adolescent and adult epileptic patients.
Bonneton J; Genton P; Mesdjian E
Biopharm Drug Dispos; 1992 Aug; 13(6):411-6. PubMed ID: 1391679
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?
Svinarov DA; Pippenger CE
Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916
[TBL] [Abstract][Full Text] [Related]
13. How suitable are currently used carbamazepine immunoassays for quantifying carbamazepine-10,11-epoxide in serum samples?
Hermida J; Tutor JC
Ther Drug Monit; 2003 Jun; 25(3):384-8. PubMed ID: 12766569
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing serum levels of carbamazepine and carbamazepine-10,11-epoxide in children.
Altafullah I; Talwar D; Loewenson R; Olson K; Lockman LA
Epilepsy Res; 1989; 4(1):72-80. PubMed ID: 2753022
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
[TBL] [Abstract][Full Text] [Related]
16. Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.
MacKichan JJ; Duffner PK; Cohen ME
Br J Clin Pharmacol; 1981 Jul; 12(1):31-7. PubMed ID: 7248139
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of carbamazepine and its 10,11-epoxide metabolite in children.
Rane A; Höjer B; Wilson JT
Clin Pharmacol Ther; 1976 Mar; 19(3):276-83. PubMed ID: 1261166
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive study of the relation between serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites with age, weight, dose, and clearances in epileptic children.
Liu H; Delgado MR
Epilepsia; 1994; 35(6):1221-9. PubMed ID: 7988515
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent pharmacokinetics of carbamazepine in rats: determination of the formation clearance of carbamazepine-10,11-epoxide.
Remmel RP; Sinz MW; Cloyd JC
Pharm Res; 1990 May; 7(5):513-7. PubMed ID: 2367320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
